New therapy aims to break cycle of child sexual abuse
NCT ID NCT06126926
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested a 32-week group therapy program for adult men in prison who have committed child sexual abuse. The goal was to see if the program is feasible and can reduce factors linked to reoffending. Ten men participated, and researchers measured changes in risk, coping, and emotional health. This early-stage research aims to inform a larger, multinational study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
group therapy
What this could lead to
If successful, this could point toward an effective program to reduce the risk of reoffending among men who have committed child sexual abuse.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply broadly. It tests feasibility, not effectiveness, and many measures are self-reported.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILD SEXUAL ABUSE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55414, United States